Pharma Journalist - Page 784 of 937 -

Arcturus Partners With Thermo Fisher on Cystic Fibrosis mRNA Therapy

Lonza Secures Nona’s BBB Technology for CNS Drug Development

Ipsen Acquires Memo Therapeutics to Advance BK Virus Treatment

FDA approves IND application for Moleac’s Phase 1 study MLC1501

Prometic receives Rare Pediatric Disease Designation from FDA

Vanda Pharmaceutical’s HETLIOZ for symptoms of jet lag disorder

MyBiotics signs second option agreement with Ferring Holding for the validation

Benitec Biopharma initiates Phase 2 Oncology Study in Australia

Trovagene confirms enrollment of First patient for Cycle 1 Treatment with PCM-075

Lyric finishes enrollment in Phase 2 PRROMOTE Study of LP101 in Enteral Feeding Intolerance

Glenmark Pharmaceuticals presents New Data on Ryaltris for treating SAR at AAAAI/WAO